Total Payments
$298,865
2024 Payments
$51,097
Companies
25
Transactions
502
Medicare Patients
2,096
Medicare Billing
$749,105
Payment Breakdown by Category
Other$216,530 (72.5%)
Travel$38,329 (12.8%)
Consulting$34,049 (11.4%)
Food & Beverage$9,956 (3.3%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $159,220 | 82 | 53.3% |
| Honoraria | $50,884 | 27 | 17.0% |
| Travel and Lodging | $38,329 | 143 | 12.8% |
| Consulting Fee | $34,049 | 17 | 11.4% |
| Food and Beverage | $9,956 | 229 | 3.3% |
| Compensation for serving as faculty or as a speaker for a non-accredited and noncertified continuing education program | $6,426 | 4 | 2.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Amneal Pharmaceuticals LLC | $71,119 | 60 | $0 (2024) |
| ABBVIE INC. | $54,610 | 81 | $0 (2024) |
| MDD US Operations, LLC | $50,043 | 61 | $0 (2024) |
| Acorda Therapeutics, Inc | $49,023 | 42 | $0 (2024) |
| Abbott Laboratories | $29,102 | 67 | $0 (2024) |
| US WorldMeds, LLC | $16,841 | 36 | $0 (2020) |
| Boston Scientific Corporation | $15,825 | 57 | $0 (2024) |
| MITSUBISHI TANABE PHARMA AMERICA, INC. | $6,751 | 9 | $0 (2024) |
| Medtronic, Inc. | $2,781 | 24 | $0 (2022) |
| Medtronic USA, Inc. | $1,691 | 12 | $0 (2018) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $51,097 | 110 | ABBVIE INC. ($13,093) |
| 2023 | $52,644 | 111 | MDD US Operations, LLC ($18,109) |
| 2022 | $28,306 | 53 | Amneal Pharmaceuticals LLC ($9,347) |
| 2021 | $32,941 | 51 | AbbVie Inc. ($13,281) |
| 2020 | $40,868 | 49 | Amneal Pharmaceuticals LLC ($12,670) |
| 2019 | $90,109 | 104 | Acorda Therapeutics, Inc ($43,411) |
| 2018 | $2,269 | 17 | Medtronic USA, Inc. ($1,671) |
| 2017 | $631.52 | 7 | Abbott Laboratories ($611.28) |
All Payment Transactions
502 individual payment records from CMS Open Payments — Page 1 of 21
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/19/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $23.18 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 12/18/2024 | MDD US Operations, LLC | Gocovri (Drug) | Food and Beverage | In-kind items and services | $17.93 | General |
| Category: AMANTADINE | ||||||
| 12/10/2024 | ACADIA Pharmaceuticals Inc | NUPLAZID (Drug) | Food and Beverage | In-kind items and services | $13.45 | General |
| Category: PARKINSONS DISEASE PSYCHOSIS | ||||||
| 12/09/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $19.71 | General |
| Category: Neuropsychiatry | ||||||
| 12/09/2024 | ACADIA Pharmaceuticals Inc | NUPLAZID (Drug) | Food and Beverage | In-kind items and services | $2.63 | General |
| Category: PARKINSONS DISEASE PSYCHOSIS | ||||||
| 12/04/2024 | ABBVIE INC. | VYALEV (Drug) | Food and Beverage | In-kind items and services | $27.62 | General |
| Category: NEUROSCIENCE | ||||||
| 12/03/2024 | Boston Scientific Corporation | — | Food and Beverage | In-kind items and services | $7.89 | General |
| Category: General - DBS_NMD | ||||||
| 11/25/2024 | Boston Scientific Corporation | Vercise (Device) | Food and Beverage | In-kind items and services | $16.47 | General |
| Category: Vercise_NMD | ||||||
| 11/11/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $38.78 | General |
| Category: Neuropsychiatry | ||||||
| 10/30/2024 | ABBVIE INC. | VYALEV (Drug) | Food and Beverage | In-kind items and services | $25.71 | General |
| Category: NEUROSCIENCE | ||||||
| 10/21/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $25.56 | General |
| Category: Neuropsychiatry | ||||||
| 10/10/2024 | Boston Scientific Corporation | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $820.00 | General |
| Category: General - DBS_NMD | ||||||
| 10/10/2024 | Boston Scientific Corporation | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $410.00 | General |
| Category: General - DBS_NMD | ||||||
| 10/03/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $16.70 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 09/29/2024 | ABBVIE INC. | DUOPA (Drug) | Food and Beverage | In-kind items and services | $32.33 | General |
| Category: NEUROSCIENCE | ||||||
| 09/26/2024 | ABBVIE INC. | DUOPA (Drug) | Food and Beverage | In-kind items and services | $15.28 | General |
| Category: NEUROSCIENCE | ||||||
| 09/12/2024 | MITSUBISHI TANABE PHARMA AMERICA, INC. | — | Consulting Fee | Cash or cash equivalent | $4,400.00 | General |
| 09/12/2024 | MDD US Operations, LLC | Apokyn (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,520.00 | General |
| Category: APOMORPHINE HYDROCHLORIDE | ||||||
| 09/12/2024 | MDD US Operations, LLC | Apokyn (Drug) | Travel and Lodging | In-kind items and services | $40.20 | General |
| Category: APOMORPHINE HYDROCHLORIDE | ||||||
| 09/04/2024 | ACADIA Pharmaceuticals Inc | NUPLAZID (Drug) | Food and Beverage | In-kind items and services | $24.55 | General |
| Category: PARKINSONS DISEASE PSYCHOSIS | ||||||
| 08/29/2024 | MITSUBISHI TANABE PHARMA AMERICA, INC. | — | Consulting Fee | Cash or cash equivalent | $1,100.00 | General |
| 08/29/2024 | Amneal Pharmaceuticals LLC | RYTARY (Drug) | Food and Beverage | In-kind items and services | $15.64 | General |
| Category: NEUROLOGY | ||||||
| 08/27/2024 | ABBVIE INC. | DUOPA (Drug) | Food and Beverage | In-kind items and services | $7.04 | General |
| Category: NEUROSCIENCE | ||||||
| 08/22/2024 | MDD US Operations, LLC | Apokyn (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,520.00 | General |
| Category: APOMORPHINE HYDROCHLORIDE | ||||||
| 08/22/2024 | MDD US Operations, LLC | Apokyn (Drug) | Travel and Lodging | In-kind items and services | $26.80 | General |
| Category: APOMORPHINE HYDROCHLORIDE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 13 | 575 | 25,994 | $619,649 | $199,103 |
| 2022 | 14 | 419 | 33,112 | $854,857 | $227,622 |
| 2021 | 17 | 684 | 28,970 | $856,327 | $230,076 |
| 2020 | 12 | 418 | 10,981 | $348,014 | $92,304 |
Total Patients
2,096
Total Services
99,057
Medicare Billing
$749,105
Procedure Codes
56
All Medicare Procedures & Services
56 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| J0585 | Injection, onabotulinumtoxina, 1 unit | Office | 2023 | 29 | 23,700 | $367,400 | $116,460 | 31.7% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 105 | 157 | $54,669 | $21,698 | 39.7% |
| J0587 | Injection, rimabotulinumtoxinb, 100 units | Office | 2023 | 11 | 1,325 | $41,820 | $12,264 | 29.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 97 | 139 | $38,530 | $11,724 | 30.4% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 62 | 62 | $30,917 | $10,465 | 33.8% |
| G2212 | Prolonged office or other outpatient evaluation and management service(s) beyond the maximum required time of the primary procedure which has been selected using total time on the date of the primary service; each additional 15 minutes by the physician or | Office | 2023 | 133 | 283 | $22,923 | $7,121 | 31.1% |
| 64616 | Injection of chemical for paralysis of nerve muscles on side of neck excluding voice box | Office | 2023 | 16 | 37 | $17,146 | $5,544 | 32.3% |
| 95984 | Electronic analysis of implanted brain, spinal cord, or peripheral neurostimulator generator with brain stimulator programming, each additional 15 minutes with qualified health professional | Office | 2023 | 19 | 101 | $12,234 | $3,366 | 27.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 33 | 49 | $9,751 | $3,114 | 31.9% |
| 95874 | Needle measurement of electrical activity in muscle with injection of chemical for paralysis of nerve muscle | Office | 2023 | 20 | 46 | $7,969 | $2,720 | 34.1% |
| 95983 | Electronic analysis of implanted brain, spinal cord, or peripheral neurostimulator generator with brain stimulator programming, first 15 minutes with qualified health professional | Office | 2023 | 22 | 60 | $8,430 | $2,234 | 26.5% |
| 64611 | Injection of chemical for paralysis of salivary glands on both sides of mouth | Office | 2023 | 16 | 20 | $6,061 | $1,748 | 28.8% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 12 | 15 | $1,799 | $644.18 | 35.8% |
| J0585 | Injection, onabotulinumtoxina, 1 unit | Office | 2022 | 31 | 28,800 | $518,400 | $140,635 | 27.1% |
| J0587 | Injection, rimabotulinumtoxinb, 100 units | Office | 2022 | 18 | 3,675 | $132,300 | $34,989 | 26.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 112 | 125 | $39,500 | $10,780 | 27.3% |
| 64616 | Injection of chemical for paralysis of nerve muscles on side of neck excluding voice box | Office | 2022 | 18 | 55 | $39,678 | $7,307 | 18.4% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 34 | 36 | $15,912 | $4,529 | 28.5% |
| 95874 | Needle measurement of electrical activity in muscle with injection of chemical for paralysis of nerve muscle | Office | 2022 | 25 | 70 | $17,080 | $4,422 | 25.9% |
| 64611 | Injection of chemical for paralysis of salivary glands on both sides of mouth | Office | 2022 | 23 | 49 | $17,787 | $4,363 | 24.5% |
| 95984 | Electronic analysis of implanted brain, spinal cord, or peripheral neurostimulator generator with brain stimulator programming, each additional 15 minutes with qualified health professional | Office | 2022 | 28 | 114 | $14,820 | $3,893 | 26.3% |
| 64612 | Injection of chemical for paralysis of nerve muscles on side of face | Office | 2022 | 14 | 27 | $16,506 | $3,599 | 21.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 36 | 49 | $10,927 | $3,342 | 30.6% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 19 | 19 | $9,196 | $2,915 | 31.7% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 16 | 34 | $8,500 | $2,700 | 31.8% |
About Dr. Juan Ramirez Castaneda, M.D
Dr. Juan Ramirez Castaneda, M.D is a Neurology healthcare provider based in San Antonio, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/15/2008. The National Provider Identifier (NPI) number assigned to this provider is 1275797680.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Juan Ramirez Castaneda, M.D has received a total of $298,865 in payments from pharmaceutical and medical device companies, with $51,097 received in 2024. These payments were reported across 502 transactions from 25 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($159,220).
As a Medicare-enrolled provider, Ramirez Castaneda has provided services to 2,096 Medicare beneficiaries, totaling 99,057 services with total Medicare billing of $749,105. Data is available for 4 years (2020–2023), covering 56 distinct procedure/service records.
Ad
Practice Information
- Specialty Neurology
- Other Specialties Internal Medicine
- Location San Antonio, TX
- Active Since 07/15/2008
- Last Updated 05/08/2023
- Taxonomy Code 2084N0400X
- Entity Type Individual
- NPI Number 1275797680
Products in Payments
- RYTARY (Drug) $62,967
- DUOPA (Drug) $53,717
- INBRIJA (Drug) $48,822
- APOKYN (Drug) $35,923
- Neuromodulation Dspsbls and Accs (Device) $13,278
- Apokyn (Drug) $11,415
- INFINITY (Device) $9,976
- MYOBLOC (Biological) $9,765
- Xadago (Drug) $3,039
- Infinity DBS Pulse Generators (Device) $2,485
- ACTIVA (Device) $1,691
- PERCEPT PC BRAINSENSE (Device) $1,588
- Vercise (Device) $1,583
- VERCISE (Device) $1,563
- PROCLAIM (Device) $1,393
- Proclaim Family of SCS IPGs (Device) $1,351
- Percept (Device) $1,193
- GENERAL DBS (Device) $1,083
- DBS Accessories (Device) $611.28
- SPECTRA WAVEWRITER (Device) $509.83
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Neurology Doctors in San Antonio
Ann Bass, M.d, M.D
Neurology — Payments: $2.4M
Neurology $2.4M
Dr. Santiago Restrepo
Neurology — Payments: $534,626
Neurology $534,626
Dr. Maria Alvarez, M.d, M.D
Neurology — Payments: $184,216
Neurology $184,216
Dr. Rebecca Romero, Md, MD
Neurology — Payments: $165,343
Neurology $165,343
Dr. Lee Birnbaum, M.d, M.D
Neurology — Payments: $131,531
Neurology $131,531
Dr. Ratna Bhavaraju-Sanka, M.d, M.D
Neurology — Payments: $79,621
Neurology $79,621